International Horizon Scanning Initiative Moves Forward
An initiative that will improve payers’ ability to negotiate prices for disruptive new drugs is closer to fruition.
You may also be interested in...
Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.
Two orphan drugs, Chiesi’s Proscybi and Insmed’s Arikayce, were rejected for funding on the Scottish National Health Service.
The Cuban government has approved the country’s home grown COVID-19 vaccine for emergency use in children, while Mexico is poised to authorize another Cuban vaccine.